Inhibition of the alloantibody response by CD95 ligand

被引:75
|
作者
Arai, H
Chan, SY
Bishop, DK
Nabel, GJ
机构
[1] UNIV MICHIGAN,HOWARD HUGHES MED INST,MED CTR,DEPT INTERNAL MED,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,HOWARD HUGHES MED INST,MED CTR,DEPT BIOL CHEM,ANN ARBOR,MI 48109
[3] UNIV MICHIGAN,DEPT SURG,SECT GEN SURG,ANN ARBOR,MI 48109
关键词
D O I
10.1038/nm0897-843
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the effect of Fas/APO1-ligand (CD95L) gene transfer on allogeneic immune responses in vivo. A colon carcinoma cell line from BALB/c mice, CT26, was stably transfected with a vector encoding mouse CD95L and was inoculated into C57BL/6 mice. CD95L expression markedly reduced allogeneic cytotoxic T lymphocyte and helper T lymphocyte activity directed toward CT26. Strikingly, expression of CD95L on these allogeneic tumors completely inhibited the generation of alloantibodies of both IgM and IgG subclasses. Thus, CD95L inhibited alloantibody production and conferred localized immune suppression through this mechanism. These results provide insight into the role of CD95L in regulating the alloantibody response and the generation of local immune responses.
引用
收藏
页码:843 / 848
页数:6
相关论文
共 50 条
  • [1] Inhibition of the alloantibody response by CD95 ligand
    Hiroshi Arai
    Sherri Y. Chanz
    D. Keith Bishop
    Gary J. Nabel
    Nature Medicine, 1997, 3 : 843 - 848
  • [2] The role of CD95 and CD95 ligand in cancer
    M E Peter
    A Hadji
    A E Murmann
    S Brockway
    W Putzbach
    A Pattanayak
    P Ceppi
    Cell Death & Differentiation, 2015, 22 : 549 - 559
  • [3] The role of CD95 and CD95 ligand in cancer
    Peter, M. E.
    Hadji, A.
    Murmann, A. E.
    Brockway, S.
    Putzbach, W.
    Pattanayak, A.
    Ceppi, P.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (04): : 549 - 559
  • [4] Inhibition of CD95 ligand-mediated inflammation
    Seino, K
    Tun, T
    Ohshima, N
    Hamada, H
    Yoshino, K
    Ikeda, S
    Fukunaga, K
    Taniguchi, H
    Takada, Y
    Yuzawa, K
    Otsuka, M
    Todoroki, T
    Fukao, K
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 2038 - 2039
  • [5] Erratum: The role of CD95 and CD95 ligand in cancer
    M E Peter
    A Hadji
    A E Murmann
    S Brockway
    W Putzbach
    A Pattanayak
    P Ceppi
    Cell Death & Differentiation, 2015, 22 : 885 - 886
  • [6] Death Induced by CD95 or CD95 Ligand Elimination
    Hadji, Abbas
    Ceppi, Paolo
    Murmann, Andrea E.
    Brockway, Sonia
    Pattanayak, Abhinandan
    Bhinder, Bhavneet
    Hau, Annika
    De Chant, Shirley
    Parimi, Vamsi
    Kolesza, Piotre
    Richards, JoAnne
    Chandel, Navdeep
    Djaballah, Hakim
    Peter, Marcus E.
    CELL REPORTS, 2014, 7 (01): : 208 - 222
  • [7] Characterisation of the roles of CD95 and CD95 ligand in cord blood
    Drénou, B
    Choqueux, C
    El Ghalbzouri, A
    Blancheteau, V
    Toubert, A
    Charron, D
    Mooney, N
    BONE MARROW TRANSPLANTATION, 1998, 22 : S44 - S47
  • [8] CD95 and CD95 ligand expression in very thin melanoma
    Fearfield, LA
    Rowe, A
    Francis, N
    Fisher, C
    MacKie, RM
    Gore, ME
    Bunker, CB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 554 - 554
  • [9] CD95 ligand in graft rejection
    Nature, 6567 (682):
  • [10] CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa
    Grassmé, H
    Kirschnek, S
    Riethmueller, J
    Riehle, A
    von Kürthy, G
    Lang, F
    Weller, M
    Gulbins, E
    SCIENCE, 2000, 290 (5491) : 527 - 530